Special Edition #3: Leading Through Adversity: A CEO Roundtable On Drug Development During A Pandemic
Source: Life Science Leader
Four biopharma CEOs discuss with Rob Wright, chief editor of Life Science Leader, how they are leading their organizations and conducting drug development during the COVID-19 pandemic.
This website uses cookies to ensure you get the best experience on our website. Learn more